NCT07132515 Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
| NCT ID | NCT07132515 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Mansoura University |
| Condition | Cirrhosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-08-15 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 100 participants in total. It began in 2023-08-15 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
Eligibility Criteria
Inclusion Criteria: * Portal vein thrombosis, Cirrhosis, With or without HCC, Child A \& B Exclusion Criteria: * Platelets\<10000, Createnine \>1.9, Budd ciarri, Uncontrolled active bleeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07132515 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07132515 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07132515 currently recruiting?
Yes, NCT07132515 is actively recruiting participants. Contact the research team at dalia.tawfik97@gmail.com for enrollment information.
Where is the NCT07132515 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07132515 clinical trial?
NCT07132515 is sponsored by Mansoura University. The trial plans to enroll 100 participants.